Crossmark

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

Crossref DOI link: https://doi.org/10.1038/s41591-022-01780-9

Published Online: 2022-03-31

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Killingley, Ben

Mann, Alex J. https://orcid.org/0000-0002-3744-4604
Kalinova, Mariya

Boyers, Alison

Goonawardane, Niluka

Zhou, Jie

Lindsell, Kate

Hare, Samanjit S.

Brown, Jonathan https://orcid.org/0000-0001-6849-3962
Frise, Rebecca

Smith, Emma

Hopkins, Claire

Noulin, Nicolas

Löndt, Brandon

Wilkinson, Tom

Harden, Stephen

McShane, Helen https://orcid.org/0000-0002-2126-5142
Baillet, Mark

Gilbert, Anthony

Jacobs, Michael

Charman, Christine

Mande, Priya

Nguyen-Van-Tam, Jonathan S.

Semple, Malcolm G. https://orcid.org/0000-0001-9700-0418
Read, Robert C. https://orcid.org/0000-0002-4297-6728
Ferguson, Neil M. https://orcid.org/0000-0002-1154-8093
Openshaw, Peter J. https://orcid.org/0000-0002-7220-2555
Rapeport, Garth https://orcid.org/0000-0002-5795-6500
Barclay, Wendy S. https://orcid.org/0000-0002-3948-0895
Catchpole, Andrew P.

Chiu, Christopher https://orcid.org/0000-0003-0914-920X
Funding

Funding for this research was provided by:

Her Majesty’s Government UK through the Department of Business Energy and Industrial Strategy
License Information

Text and Data Mining valid from 2022-03-31

Version of Record valid from 2022-03-31
More Information

Article History

Received: 28 November 2021

Accepted: 9 March 2022

First Online: 31 March 2022

Competing interests

: A.B., A.P.C., A.M., B.Z.L., M.K. and N.N. are employees of hVIVO Services Ltd. and hold shares in Open Orphan and Poolbeg Pharma. A.G. is previous employee at hVIVO Services Ltd. and holds shares in Open Orphan and Poolbeg Pharma. G.R. is a co-founder of SubIntro Ltd. M.G.S. is Director of MedEx Solutions Ltd., chairs the Infectious Disease Scientific Advisory Board of Integrum Scientific LLC and holds shares in Integrum Scientific LLC and MedEx Solutions Ltd. T.W. has received research grants and/or fees from AstraZeneca, UCB, Bergenbio, Synairgen, Valneva and my mhealth (MMH) in the field of COVID-19 research. T.W. owns shares in Open Orphan and MMH. T.W. is a director of MMH. J.S.N.-V.-T. is seconded to the Department of Health and Social Care, England.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below